All listings for this product
Save on Textbooks
- AU $56.99Trending at AU $71.25
- AU $13.75Trending at AU $17.80
- AU $69.53Trending at AU $85.96
- AU $17.60Trending at AU $22.27
- AU $34.66Trending at AU $36.07
- AU $29.91Trending at AU $39.11
- AU $50.46Trending at AU $57.09
About this product
- DescriptionOne of the United States Food and Drug Administration's most difficult tasks is the assessment of risk-benefit ratios for a broad spectrum of therapeutic and prophylactic drugs. Furthermore, it is w widely recog- nized that drug, chemical or even natural substance is completely devoid of risk. Nowhere has this issue been the subject of more controversy than with steroidal contraceptive drugs. Regulated as a special class of products because of their prophylactic use in healthy individuals for prevention of pregnancy rather than for treatment of disease, steroid contraceptives drugs undergo more extensive animal safety tests than any other pharmaceutical agent. This view also contemplates the availability of alternative contraceptive measures posing fewer risks, but the use of less effective methods must take into consideration the hazards associated with pregnancy itself. In April 1983, the Food and Drug Administration and the National Insti- tutes of Health in cooperation with the World Health Organization, the Population Council, and the Agency for International Development sponsored a three-day workshop to evaluate current guidelines for preclinical safety studies of contraceptive drugs in light of our extensive kwledge of the side effects of marketed products. The meeting included presenta- tions by experts in the fields of comparative metabolism, pharmacokinetics, pharmacology, carcigenicity, toxicology, coagulation, lipid metabolism, epidemiology and pathology at a meeting of the Fertility and Maternal Health Drugs Advisory Committee of the National Center for Drugs and Biologics, Food and Drug Administration.
- PublisherSpringer-Verlag New York Inc.
- Date of Publication15/04/2013
- SubjectAgriculture & Farming
- Series TitleThe Plenum Behavior Therapy Series
- Place of PublicationNew York, NY
- Country of PublicationUnited States
- ImprintSpringer-Verlag New York Inc.
- Content Note56 black & white illustrations, biography
- Weight780 g
- Width178 mm
- Height254 mm
- Spine21 mm
- Edited byA. T. Gregoire
- Edition StatementSoftcover reprint of the original 1st ed. 1986
This item doesn't belong on this page.
Thanks, we'll look into this.